Clinical trial registry record

Algarve Active Ageing - Cardiac and Osteoarthritis Rehabilitation (A3-COR)

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Plain-language guide

Five questions to ask about this record

What this is
A clinical study registration, not a result or recommendation.
Why it may matter
The registry currently reports Unknown.
Evidence
Registered phase not reported study.
Main limitation
Registration does not prove that the intervention works, is safe, or is available to you.
What changed
Registry metadata was last updated February 8, 2024.
Where to verify
Open the primary registry below for eligibility, locations, contacts, and current status.
Registry ID
NCT05999110
Last registry update
February 8, 2024
Status
Unknown
Phase
Phase not reported
Sponsor
Associação para o Desenvolvimento do Centro Académico de Investigação e Formação Biomédica do Algarv
Enrollment
200
Countries
Portugal
Match confidence
100%
Source feed
ClinicalTrials.gov
Automated source synopsis

A registered study indexed because it matched monitored longevity research terms. Registry status: Unknown. Registration does not establish safety or effectiveness.

Evidence snapshot

What the source actually supports

Evidence stage
Phase not reported
Study design
RANDOMIZED · PARALLEL · TREATMENT · SINGLE
Evidence population
Human clinical study registration
Participants
200
Population
ALL · 50 Years
Duration
2022-06-01 to 2024-12-20
Intervention
Physical Exercise
Comparator
Control Group
Outcomes measured
Change the Level of Pain — 12 weeks; Change the Level of Function — 12 weeks; Change the Time Up and Go Test Performance — 12 weeks; Change the 30-Second Chair Stand Test Performance — 12 weeks; Change the 40m Fast Paced Walk Test Performance — 12 weeks; Change the Stair Climb Test Performance — 12 weeks; Change the 6 Minutes Walk Test Performance — 12 weeks; Change in Quality of Life — 12 weeks; Change in Peak Torque of Quadriceps and Hamstring Muscles — 12 weeks; Change in Work of Quadriceps and Hamstring Muscles — 12 weeks; Change in Power of Quadriceps and Hamstring Muscles — 12 weeks; Change in Peak torque time of Quadriceps and Hamstring Muscles — 12 weeks; Change in Force of Quadriceps and Hamstring Muscles — 12 weeks; Change in Maximal Oxygen Uptake (VO2max) — 12 weeks; Change in First Ventilatory Threshold (VT1 - VO2) — 12 weeks; Change in Respiratory Compensation Point (RCP - VO2) — 12 weeks; Change in maximal displacement of vastus lateralis and medialis, biceps femoris and semitendinous — 12 weeks; Change in contraction time of vastus lateralis and medialis, biceps femoris and semitendinous — 12 weeks; Change in Weight — 12 weeks; Change in body mass index — 12 weeks
Reported result
No reusable finding-level result is available in this record.

Main limitationThis is a study registration. No reusable structured result is available here, so it cannot show whether the intervention worked or was safe.

Safety and approvalEligibility, adverse-event details, and clinical decisions must be checked in the official registry and with qualified clinicians. Trial registration is not regulatory approval and does not establish that an intervention is available.

Source supportStructured registry protocol metadata; no finding-level conclusion is generated.

Trial stage · Phase not reportedA trial phase describes development stage; it does not establish a positive result.
Phase 1Phase 2Phase 3Phase 4

Registration and recruitment status do not establish safety, efficacy, or regulatory approval.

Why this record appears here · 100% topic match

The title, summary, or source keywords matched one or more topics followed by immortal.life. A higher percentage means a stronger topic match; it does not rate safety, effectiveness, or study quality.

  • Joint and cartilage ageing · 100%Title contains controlled term: osteoarthritis. Abstract contains controlled term: osteoarthritis. Source terminology contains: osteoarthritis. Title supplies longevity context: ageing. Study type is explicitly identified as INTERVENTIONAL.

Automated source check 100% · update recency 65%. These figures help sort records; they are not medical ratings.